RHY 1.64% 6.2¢ rhythm biosciences limited

Blood screening could come in 2024Guardant Health, a Silicon...

  1. 14 Posts.
    lightbulb Created with Sketch. 2

    Blood screening could come in 2024

    Guardant Health, a Silicon Valley company, has developed a DNA blood test called Shield it says can be prescribed by primary care doctors.

    Guardant is seeking approval from the Food and Drug Administration, which has scheduled an advisory committee hearing on March 28.


 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
0.001(1.64%)
Mkt cap ! $15.41M
Open High Low Value Volume
6.1¢ 6.2¢ 6.1¢ $1.668K 26.97K

Buyers (Bids)

No. Vol. Price($)
2 102393 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 144960 1
View Market Depth
Last trade - 15.42pm 05/07/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.